Form 4: Rezolute Inc. Chief Medical Officer Brian Kenneth Roberts Reports Acquisition of 10,000 Common Shares

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports the acquisition of 10,000 common shares at $1.88 per share on March 14, 2024.

Summary

• On March 14, 2024, Brian Kenneth Roberts, the Chief Medical Officer of Rezolute, Inc. (RZLT), acquired 10,000 common shares of the company.
• The shares were purchased at a price of $1.88 per share.
• Following the transaction, Roberts directly owns 42,552 common shares and indirectly owns 576 shares held by a minor child.
• He also indirectly holds 10,000 shares in an IRA.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but the purchase is relatively small and may not be highly significant.

Positives

• The purchase of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The purchase of shares by a company officer could have a slightly positive impact on shareholder sentiment.

Key Dates